Development of a Non-Parametric Population Pharmacokinetics Model and Bayesian Estimator for Tacrolimus in Tunisian Renal Transplant Patients

    March 2017 in “ Fundamental & Clinical Pharmacology ”
    Image of study
    TLDR The model and estimator can predict drug exposure in kidney transplant patients well.
    In a study involving 20 Tunisian renal transplant patients treated with tacrolimus, researchers aimed to develop a non-parametric population pharmacokinetics model and a Bayesian estimator. The study collected 20 full pharmacokinetics profiles, which were divided into a development dataset with 15 profiles and a validation dataset with 5 profiles. A one-compartment model with first-order elimination was found to fit the pharmacokinetics profiles well. None of the investigated covariates, including hematocrit, age, sex, and creatinine, significantly influenced the pharmacokinetics parameters. The Bayesian estimator, when combined with the best limited sampling strategy (LSS) determined by the MMopt algorithm (samples at 0, 0.5, and 4 hours), accurately estimated tacrolimus exposure in the validation dataset. There was no correlation found between tacrolimus exposure and creatinine or hematocrit levels. The study concluded that the developed model and Bayesian estimator could adequately predict tacrolimus exposure in renal transplant patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

      community Just find a cure already, I am totally done

      in Chat  161 upvotes 1 month ago
      The conversation is about hair loss treatments, with users recommending finasteride and minoxidil as effective solutions. Some users report side effects, but overall, the consensus is to use these treatments rather than waiting for a cure.

      community Breaking hair loss news! GT20029 is a resounding success!

      in Product  135 upvotes 5 months ago
      GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.

      community Medications that cause extra hair growth

      in Research/Science  121 upvotes 11 months ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community Is there any new drug that looks promising ?

      in Research/Science  26 upvotes 6 months ago
      The conversation discusses GT20029, a drug in Phase II trials that targets androgen receptors with minimal systemic effects, and TDM-105795, a growth stimulant with a different mechanism than minoxidil that may revive papilla stem cells. Both are potential new treatments for hair loss.

      community The MPB itch aka DHT itch is very real.

      in Chat  9 upvotes 1 year ago
      Hair loss itch is caused by DHT attacking follicles and stimulating nerves. Finasteride users who respond well don't experience this itch.

      community Topical Dutasteride is Here.

      in Finasteride/Dutasteride  153 upvotes 3 years ago
      The availability of Topical Dutasteride, a potential treatment for hair loss, which can be purchased without prescription from MinoxidilMax. Other treatments discussed include Topical Finasteride and PRP injections, with discussion around dosage, efficacy, side-effects and safety.